February 28, 2019 - ITFPHARMA
ITF Pharma has been named an honoree for the 2018 Patient Impact Award, presented by Life Sciences Pennsylvania, for the successful launch and approval of TIGLUTIK
Download PDF
November 30, 2018 - Adnkronos
The project: make the first move take care of your bones. The "awareness" initiative on osteoporosis is supported by Abiogen and Italfarmaco and will interest 11 scientific societies involved in the study of metabolic bone diseases.
Link to the article
September 06, 2018 - ITFPHARMA
ITF PHARMA announces FDA approval of TIGLUTIK™ (riluzole) oral suspension for the tratment of amyotrophic lateral sclerosis (ALS)
Download PDF
September 06, 2018 - ABOUTPHARMA ONLINE
Sla, Fda approva riluzolo di Italfarmaco
Download PDF (Only in italian)
June 28, 2017 - Il Giorno Milano
Malattia rara. Un accordo da 5,6 milioni per la ricerca
Download PDF
March 27, 2017 - Il Sole24 Ore
Più calcio e vitamina D per ridurre le fratture da osteoporosi e far risparmiare il Ssn
Link to the article
March 25, 2015 - Pharmakronos
L'accordo Chemi-Teva dà i suoi frutti
Link to the article
February 25, 2015 - Pharmastar
Distrofia di Duchenne, bene in fase II il givinostat, farmaco di ricerca Italfarmaco
Link to the article
March 01, 2014 - Espansione
L'industria farmaceutica in un mondo che cambia - Tavola Rotonda. Il settore farmaceutico, tra attualità e prospettive.
Link to the article
December 13, 2013 - Helsinn.com
Helsinn and Italfarmaco reinforce their alliance through the grant of rights to phase-III ghrelin receptor agonist Anamorelin in Italy
Link to the article